Table 1.
Demographic and disease characteristics of BC and BBL in Egyptian women.
| BC (n = 72)a | BBL (n = 15)a | P value | |
|---|---|---|---|
| Age (years) mean ± SD | 53.8 ± 11.5 | 55.0 ± 13.7 | .72 |
| Size (cm) (median, range) | 3 (1-12) | 7 (1-10) | <.005 |
| <2 | 11 (15.3%) | 1 (11.1%) | |
| 2-5 | 54 (75.0%) | 3 (33.3%) | |
| >5 | 7 (9.7%) | 5 (55.6%) | |
| Unknown | 0 | 6 | |
| Stage | |||
| Early (I and II) | 45 (62.5%) | ||
| Advanced (III and IV) | 23 (31.9%) | ||
| Unknown | 4 | ||
| Tumor grade | |||
| Grade I | 2 (2.8%) | ||
| Grade II | 54 (76%) | ||
| Grade III | 15 (21.1%) | ||
| Unknown | 1 | ||
| Lymph node metastasis | |||
| Positive | 35 (50.0%) | ||
| Negative | 35 (50.0%) | ||
| Unknown | 2 | ||
| Estrogen receptor | |||
| Positive | 58 (84.1%) | ||
| Negative | 11 (15.9%) | ||
| Unknown | 3 | ||
| Progesterone receptor | |||
| Positive | 54 (78.3%) | ||
| Negative | 15 (21.7%) | ||
| Unknown | 3 | ||
| HER2 | |||
| Positive | 43 (62.3%) | ||
| Negative | 26 (37.7%) | ||
| Unknown | 3 | ||
Abbreviations: BBL, benign breast lesions; BC, breast cancer; HER2, Human Epidermal Growth Factor Receptor 2.
a
Numbers in parenthesis represent the range or percent.